Junichi Hoshino

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 310 publications

Mechanistic insights into maintenance and disruption of membrane phosphatidylserine asymmetry in human erythrocytes: a survival strategy during their lifespan

Mechanistic insights into maintenance and disruption of membrane phosphatidylserine asymmetry in human erythrocytes: a survival strategy during their lifespan

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: July 01, 2026

Efficacy of Neuromuscular Electrical Stimulation in Patients on Hemodialysis: An Updated Systematic Review and Meta-analysis.

Efficacy of Neuromuscular Electrical Stimulation in Patients on Hemodialysis: An Updated Systematic Review and Meta-analysis.

Journal: Kidney medicine
Published: June 01, 2026

Crystalglobulin-Induced Nephropathy and Cardiac Nonamyloidotic Immunoglobulin Deposition Disease: A Fatal Case Report.

Crystalglobulin-Induced Nephropathy and Cardiac Nonamyloidotic Immunoglobulin Deposition Disease: A Fatal Case Report.

Journal: Kidney medicine
Published: May 01, 2026

Nationwide attribute-based cross-classification reveals distinct risk patterns of major complications in ADPKD.

Nationwide attribute-based cross-classification reveals distinct risk patterns of major complications in ADPKD.

Journal: Clinical and experimental nephrology
Published: April 29, 2026

The Next-Generation CKD Heat Map: Hyperfiltration and eGFR Slope in the Cardiorenal Continuum.

The Next-Generation CKD Heat Map: Hyperfiltration and eGFR Slope in the Cardiorenal Continuum.

Journal: Kidney international reports
Published: April 20, 2026

Association of prior Angiotensin receptor-neprilysin inhibitor use with the initial eGFR dip after initiation of SGLT2 inhibitors in patients with chronic kidney disease.

Association of prior Angiotensin receptor-neprilysin inhibitor use with the initial eGFR dip after initiation of SGLT2 inhibitors in patients with chronic kidney disease.

Journal: Clinical and experimental nephrology
Published: March 14, 2026

Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case Report.

Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case Report.

Journal: Kidney medicine
Published: March 02, 2026

Combination effect of nutrition and exercise intervention in patients with maintenance dialysis: A systematic review and meta-analysis.

Combination effect of nutrition and exercise intervention in patients with maintenance dialysis: A systematic review and meta-analysis.

Journal: Clinical nutrition ESPEN
Published: March 01, 2026

Nationwide epidemiological survey of autosomal dominant polycystic kidney disease in Japan in 2022.

Nationwide epidemiological survey of autosomal dominant polycystic kidney disease in Japan in 2022.

Journal: Clinical and experimental nephrology
Published: February 23, 2026

Hydroxychloroquine-induced renal phospholipidosis manifesting as proximal tubulopathy in systemic lupus erythematosus.

Hydroxychloroquine-induced renal phospholipidosis manifesting as proximal tubulopathy in systemic lupus erythematosus.

Journal: BMC nephrology
Published: February 18, 2026

Intradialytic Renal Rehabilitation and Mortality: Results from the Registry of Active Renal Rehabilitation in Dialysis Patients (REVEAL-D).

Intradialytic Renal Rehabilitation and Mortality: Results from the Registry of Active Renal Rehabilitation in Dialysis Patients (REVEAL-D).

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 13, 2026

Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study.

Patient characteristics and treatment efficacy after switching to hypoxia-inducible factor-prolyl hydroxylase inhibitors from erythropoiesis-stimulating agents in non-dialysis-dependent chronic kidney disease patients: the Reach-J CKD cohort study.

Journal: BMC nephrology
Published: January 09, 2026
Showing 1-12 of 310

Last Updated: 09/26/2026